Boston Scientific Statistics
Total Valuation
BSX has a market cap or net worth of $152.12 billion. The enterprise value is $162.83 billion.
| Market Cap | 152.12B |
| Enterprise Value | 162.83B |
Important Dates
The next estimated earnings date is Wednesday, July 23, 2025, before market open.
| Earnings Date | Jul 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BSX has 1.48 billion shares outstanding. The number of shares has increased by 1.11% in one year.
| Current Share Class | 1.48B |
| Shares Outstanding | 1.48B |
| Shares Change (YoY) | +1.11% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 92.74% |
| Float | 1.48B |
Valuation Ratios
The trailing PE ratio is 75.03 and the forward PE ratio is 34.88. BSX's PEG ratio is 2.84.
| PE Ratio | 75.03 |
| Forward PE | 34.88 |
| PS Ratio | 8.60 |
| Forward PS | 7.64 |
| PB Ratio | 6.82 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 50.38 |
| P/OCF Ratio | 39.83 |
| PEG Ratio | 2.84 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.90, with an EV/FCF ratio of 54.03.
| EV / Earnings | 80.13 |
| EV / Sales | 9.28 |
| EV / EBITDA | 35.90 |
| EV / EBIT | 50.16 |
| EV / FCF | 54.03 |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.52.
| Current Ratio | 1.45 |
| Quick Ratio | 0.68 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 2.53 |
| Debt / FCF | 3.88 |
| Interest Coverage | 10.21 |
Financial Efficiency
Return on equity (ROE) is 9.50% and return on invested capital (ROIC) is 6.21%.
| Return on Equity (ROE) | 9.50% |
| Return on Assets (ROA) | 5.28% |
| Return on Invested Capital (ROIC) | 6.21% |
| Return on Capital Employed (ROCE) | 9.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.46 |
| Inventory Turnover | 2.04 |
Taxes
In the past 12 months, BSX has paid $454.00 million in taxes.
| Income Tax | 454.00M |
| Effective Tax Rate | 18.32% |
Stock Price Statistics
The stock price has increased by +35.93% in the last 52 weeks. The beta is 0.69, so BSX's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | +35.93% |
| 50-Day Moving Average | 100.85 |
| 200-Day Moving Average | 93.85 |
| Relative Strength Index (RSI) | 49.40 |
| Average Volume (20 Days) | 6,767,843 |
Short Selling Information
The latest short interest is 16.75 million, so 1.13% of the outstanding shares have been sold short.
| Short Interest | 16.75M |
| Short Previous Month | 14.49M |
| Short % of Shares Out | 1.13% |
| Short % of Float | 1.14% |
| Short Ratio (days to cover) | 2.40 |
Income Statement
In the last 12 months, BSX had revenue of $17.55 billion and earned $2.03 billion in profits. Earnings per share was $1.37.
| Revenue | 17.55B |
| Gross Profit | 12.02B |
| Operating Income | 3.25B |
| Pretax Income | n/a |
| Net Income | 2.03B |
| EBITDA | 4.54B |
| EBIT | 3.25B |
| Earnings Per Share (EPS) | $1.37 |
Balance Sheet
The company has $725.00 million in cash and $11.71 billion in debt, giving a net cash position of -$10.98 billion or -$7.42 per share.
| Cash & Cash Equivalents | 725.00M |
| Total Debt | 11.71B |
| Net Cash | -10.98B |
| Net Cash Per Share | -$7.42 |
| Equity (Book Value) | 22.45B |
| Book Value Per Share | 15.02 |
| Working Capital | 2.28B |
Cash Flow
In the last 12 months, operating cash flow was $3.81 billion and capital expenditures -$798.00 million, giving a free cash flow of $3.01 billion.
| Operating Cash Flow | 3.81B |
| Capital Expenditures | -798.00M |
| Free Cash Flow | 3.01B |
| FCF Per Share | $2.04 |
Margins
Gross margin is 68.45%, with operating and profit margins of 18.49% and 11.58%.
| Gross Margin | 68.45% |
| Operating Margin | 18.49% |
| Pretax Margin | 14.12% |
| Profit Margin | 11.58% |
| EBITDA Margin | 25.84% |
| EBIT Margin | 18.49% |
| FCF Margin | 17.17% |
Dividends & Yields
BSX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.11% |
| Shareholder Yield | -1.11% |
| Earnings Yield | 1.34% |
| FCF Yield | 1.98% |
Analyst Forecast
The average price target for BSX is $111.64, which is 8.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $111.64 |
| Price Target Difference | 8.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (5Y) | 10.68% |
| EPS Growth Forecast (5Y) | 29.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 6, 2003. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 6, 2003 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BSX has an Altman Z-Score of 5.13 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.13 |
| Piotroski F-Score | 5 |